Atlas Trials

Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)

Clinical trial NCT02125877 · COMPLETED

Trial details

NCT number
NCT02125877
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Iron Overload Due to Transfusion-dependant Anemias
Start date
2014-07-08
Primary completion
2016-02-24
Enrollment
173

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.